1996
DOI: 10.3892/ijo.9.1.9
|View full text |Cite
|
Sign up to set email alerts
|

Expression of ets family of genes in systemic lupus erythematosus and Sjogren's syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
50
1

Year Published

2000
2000
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 40 publications
(52 citation statements)
references
References 0 publications
1
50
1
Order By: Relevance
“…These mice also have an increased number of mature B-cells, which have a reduced activation-induced apoptotic response compared with B-cells from wild type animals (23). The possible role of Fli-1 in autoimmunity is further supported by our observation of elevated expression of Fli-1 mRNA in lymphocytes from patients with systemic lupus erythematosus (24). In addition, it has been demonstrated that Fli-1 expression promotes a megakaryocytic phenotype in K562 cells and increases the expression of megakaryocytic genes (25)(26)(27).…”
mentioning
confidence: 53%
“…These mice also have an increased number of mature B-cells, which have a reduced activation-induced apoptotic response compared with B-cells from wild type animals (23). The possible role of Fli-1 in autoimmunity is further supported by our observation of elevated expression of Fli-1 mRNA in lymphocytes from patients with systemic lupus erythematosus (24). In addition, it has been demonstrated that Fli-1 expression promotes a megakaryocytic phenotype in K562 cells and increases the expression of megakaryocytic genes (25)(26)(27).…”
mentioning
confidence: 53%
“…Over-expression of Fli1 in otherwise healthy mice results in an abnormal expansion of autoreactive lymphocytes, production of autoantibodies and the development of an autoimmune kidney disease similar to that observed in murine models of lupus (Zhang et al, 1995). Subsequently, it was observed that Fli1 is over-expressed in the lymphocytes of lupus prone mouse models MRL/lpr and NZB/NZW f1 (Georgiou, 1996;Zhang et al, 2004) and in PBMCs from human lupus patients (Georgiou, 1996). Interestingly, reducing Fli1 levels by approximately 50% in the MRL/lpr mouse model decreased autoantibody production, decreased proteinuria and pathological renal scores, altered the numbers of CD8+ and naive T cells and significantly increased survival (Zhang et al, 2004).…”
Section: Introductionmentioning
confidence: 79%
“…Additionally, we identified a GA n microsatellite in the Fli1 promoter that is polymorphic in lupus prone mice and its length is inversely proportional to promoter activity in a T cell line. Because the immune system and lupus disease expression are sensitive to the levels of Fli1 (Georgiou, 1996;Zhang et al, 1995;Zhang et al, 2004), further studies to decipher the precise control of Fli1 gene expression in lymphocytes will be important for understanding the pathogenesis of lupus and also may provide insight into the role of Fli1 in hematopoietic malignancies. 5' deletion analysis of Fli1 promoter activity in B and T cells.…”
Section: Discussionmentioning
confidence: 99%
“…Overexpression of Fli1 in all tissues of transgenic mice results in death from progressive immunological renal disease associated with an increased number of autoreactive T and B lymphocytes (41). The possible role of FLI1 in autoimmunity is further supported by our recent observation of elevated expression of FLI1 mRNA in lymphocytes from patients with systemic lupus erythematosus (12). Overexpression of Fli1 results in an increased number of mature B cells, which have a reduced activationinduced apoptotic response compared to B cells from wild-type animals (41).…”
mentioning
confidence: 85%